Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To examine differences in the incidence and spectrum of diseases, as well as duration of inpatient stay, between HIV-seronegative and HIV-seropositive narcotic drug, users (NDU). DESIGN: Retrospective analysis of 9 years of experience. Data collection by chart review using preset criteria for diagnoses. Estimation of hospital admission densities by assuming a dynamic but stable population of 2000 NDU (with a mean HIV-seroprevalence of 25%) throughout the study period. PATIENTS: Comprising 314 HIV-seronegative NDU. 217 HIV-seropositive NDU, and 10 NDU with admissions registered in either group (from a total of 1011 admissions). RESULTS: The overall admission incidence density was 35 and 120 per 1000 person-years among HIV-seronegative NDU and HIV-seropositive NDU, respectively [risk ratio (RR) 3.5, 95% confidence interval (CI) 3.2-3.7]. Compared with seronegative NDU, HIV-seropositive NDU were more frequently admitted for various non-opportunistic infections (RR 7.2, 95% CI 6.1-8.4), including pneumonia (RR 10.9, 95% CI 7.6-16.6), tuberculosis (RR 30.0, 95% CI 3.6-233.8), soft-tissue infections (RR 3.5, 95% CI 1.7-7.2), osteoarticular infections (RR 6.0, 95% CI 1.5-23.9), endocarditis (RR 5.3, 95% CI 1.5-17.9), and various other infections (RR 5.8, 95% CI 3.2-10.5). HIV-seropositive NDU were also more frequently admitted for non-infectious medical complications (RR 2.3, 95% CI 1.8-3.0). Seronegative NDU had a shorter median inpatient stay (2 versus 9 days, P < 0.00001). HIV infection accounted for an estimated excess burden of at least 2700 inpatient care days in 9 years among the 500 local HIV-seropositive NDU. CONCLUSIONS: Among NDU, HIV infection adds considerable excess burden in terms of severe complications needing inpatient care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zimmerli, W. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp0910753 · Cited by 651
Self-citationStaphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies
Bassetti, S., & Battegay, M. (2004) · Infection · doi:10.1007/s15010-004-3106-0 · Cited by 118
“The epidemiology of severe medical complications among IDUs before injection opiate maintenance programs were available was carefully investigated by Scheidegger and Zimmerli [2, 3].”
MethodInfluentialInfective endocarditis in intravenous drug abusers
Miró, J. M., Moreno, A., & Mestres, C. A. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0007-9 · Cited by 68
“Several epidemiologic studies [21,81, 82 ] have shown that HIV infection is associated with a several-fold increased risk of endocarditis in IVDA.”
Bassetti, S., Hoffmann, M., Bucher, H. C., Fluckiger, U., & Battegay, M. (2002) · Clinical Infectious Diseases · doi:10.1086/338876 · Cited by 25
Rossow, J. A., Gharpure, R., Brennan, J., Relan, P., Williams, S. R., Vallabhaneni, S., Jackson, B. R., Graber, C. R., Hillis, S. R., Schaffner, W., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa024 · Cited by 17
Metadata
- Authors
- Scheidegger, C., & Zimmerli, W.
- Venue
- AIDS
- Published
- 1996-10
- Volume
- 10
- Issue
- 12
- Pages
- 1407-1414
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2064044324
- Cited by
- 33
- References
- 0
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. https://app.cochat.ai/papers/10.1097/00002030-199610000-00014
- The paper
- Scheidegger, C., & Zimmerli, W. (1996). Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS. https://doi.org/10.1097/00002030-199610000-00014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.